<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Chemomab Therapeutics Ltd. (CMMB) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/cmmb/filings</link>
    <description>Latest company filings for Chemomab Therapeutics Ltd. (CMMB) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 21:53:30 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/cmmb/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002672/zk2635329.htm</link>
      <guid isPermaLink="false">0001178913-26-002672</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002423/zk2635214.htm</link>
      <guid isPermaLink="false">0001178913-26-002423</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002274/zk2635146.htm</link>
      <guid isPermaLink="false">0001178913-26-002274</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002070/xslF345X06/zk2635059.xml</link>
      <guid isPermaLink="false">0001178913-26-002070</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002068/xslF345X06/zk2635030.xml</link>
      <guid isPermaLink="false">0001178913-26-002068</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002066/xslF345X06/zk2635048.xml</link>
      <guid isPermaLink="false">0001178913-26-002066</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002064/xslF345X06/zk2635031.xml</link>
      <guid isPermaLink="false">0001178913-26-002064</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002062/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-002062</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326002060/xslF345X06/zk2635058.xml</link>
      <guid isPermaLink="false">0001178913-26-002060</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326001962/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001962</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326001960/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001960</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 20-F]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326001593/zk2634510.htm</link>
      <guid isPermaLink="false">0001178913-26-001593</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 20-F (20-F) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>20-F</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326001571/zk2634884.htm</link>
      <guid isPermaLink="false">0001178913-26-001571</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891326001550/zk2634872.htm</link>
      <guid isPermaLink="false">0001178913-26-001550</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000121106026000005/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001211060-26-000005</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000199560126000002/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001995601-26-000002</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325003932/zk2534057.htm</link>
      <guid isPermaLink="false">0001178913-25-003932</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-21.]]></description>
      <pubDate>Fri, 21 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325003015/zk2533691.htm</link>
      <guid isPermaLink="false">0001178913-25-003015</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-22.]]></description>
      <pubDate>Fri, 22 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325002894/zk2533584.htm</link>
      <guid isPermaLink="false">0001178913-25-002894</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-14.]]></description>
      <pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000199560125000004/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001995601-25-000004</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-08-11.]]></description>
      <pubDate>Mon, 11 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325002465/zk2533479.htm</link>
      <guid isPermaLink="false">0001178913-25-002465</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-07-25.]]></description>
      <pubDate>Fri, 25 Jul 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325002461/zk2532755.htm</link>
      <guid isPermaLink="false">0001178913-25-002461</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Prospectus supplement (424B5) on 2025-07-25.]]></description>
      <pubDate>Fri, 25 Jul 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325002278/zk2533404.htm</link>
      <guid isPermaLink="false">0001178913-25-002278</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-07-01.]]></description>
      <pubDate>Tue, 01 Jul 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000094787125000624/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000947871-25-000624</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2025-06-23.]]></description>
      <pubDate>Mon, 23 Jun 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001967/zk2533263.htm</link>
      <guid isPermaLink="false">0001178913-25-001967</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-05-27.]]></description>
      <pubDate>Tue, 27 May 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001807/zk2533206.htm</link>
      <guid isPermaLink="false">0001178913-25-001807</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-05-15.]]></description>
      <pubDate>Thu, 15 May 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001306/zk2533017.htm</link>
      <guid isPermaLink="false">0001178913-25-001306</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-04-15.]]></description>
      <pubDate>Tue, 15 Apr 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001274/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001178913-25-001274</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-04-10.]]></description>
      <pubDate>Thu, 10 Apr 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 20-F]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001205/zk2532902.htm</link>
      <guid isPermaLink="false">0001178913-25-001205</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 20-F (20-F) on 2025-04-04.]]></description>
      <pubDate>Fri, 04 Apr 2025 12:00:00 GMT</pubDate>
      <category>20-F</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325001065/zk2532931.htm</link>
      <guid isPermaLink="false">0001178913-25-001065</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-03-27.]]></description>
      <pubDate>Thu, 27 Mar 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325000959/zk2532900.htm</link>
      <guid isPermaLink="false">0001178913-25-000959</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-03-20.]]></description>
      <pubDate>Thu, 20 Mar 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325000658/zk2532798.htm</link>
      <guid isPermaLink="false">0001178913-25-000658</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-03-03.]]></description>
      <pubDate>Mon, 03 Mar 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891325000542/zk2532752.htm</link>
      <guid isPermaLink="false">0001178913-25-000542</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2025-02-19.]]></description>
      <pubDate>Wed, 19 Feb 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/999999999524003723/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-24-003723</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a EFFECT (EFFECT) on 2024-12-10.]]></description>
      <pubDate>Tue, 10 Dec 2024 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[CMMB: POS AM]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003893/zk2432420.htm</link>
      <guid isPermaLink="false">0001178913-24-003893</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a POS AM (POS AM) on 2024-12-02.]]></description>
      <pubDate>Mon, 02 Dec 2024 12:00:00 GMT</pubDate>
      <category>POS AM</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Activist ownership stake (update) (SC 13D/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003877/zk2432412.htm</link>
      <guid isPermaLink="false">0001178913-24-003877</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Activist ownership stake (update) (SC 13D/A) on 2024-11-29.]]></description>
      <pubDate>Fri, 29 Nov 2024 12:00:00 GMT</pubDate>
      <category>SC 13D/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Passive ownership stake (SC 13G)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000199560124000007/CMMB13g.htm</link>
      <guid isPermaLink="false">0001995601-24-000007</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Passive ownership stake (SC 13G) on 2024-11-21.]]></description>
      <pubDate>Thu, 21 Nov 2024 12:00:00 GMT</pubDate>
      <category>SC 13G</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003747/zk2432350.htm</link>
      <guid isPermaLink="false">0001178913-24-003747</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2024-11-18.]]></description>
      <pubDate>Mon, 18 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003737/zk2432348.htm</link>
      <guid isPermaLink="false">0001178913-24-003737</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Prospectus supplement (424B5) on 2024-11-15.]]></description>
      <pubDate>Fri, 15 Nov 2024 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003682/zk2432324.htm</link>
      <guid isPermaLink="false">0001178913-24-003682</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2024-11-14.]]></description>
      <pubDate>Thu, 14 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003272/zk2432124.htm</link>
      <guid isPermaLink="false">0001178913-24-003272</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2024-10-11.]]></description>
      <pubDate>Fri, 11 Oct 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Activist ownership stake (update) (SC 13D/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000094787124000757/ss3873211_sc13da.htm</link>
      <guid isPermaLink="false">0000947871-24-000757</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Activist ownership stake (update) (SC 13D/A) on 2024-09-16.]]></description>
      <pubDate>Mon, 16 Sep 2024 12:00:00 GMT</pubDate>
      <category>SC 13D/A</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000094787124000751/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000947871-24-000751</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Insider sale notice (144) on 2024-09-12.]]></description>
      <pubDate>Thu, 12 Sep 2024 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324003001/zk2432003.htm</link>
      <guid isPermaLink="false">0001178913-24-003001</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 424B3 (424B3) on 2024-09-09.]]></description>
      <pubDate>Mon, 09 Sep 2024 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/999999999524002741/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-24-002741</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a EFFECT (EFFECT) on 2024-09-06.]]></description>
      <pubDate>Fri, 06 Sep 2024 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324002940/filename1.htm</link>
      <guid isPermaLink="false">0001178913-24-002940</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Company correspondence (CORRESP) on 2024-09-04.]]></description>
      <pubDate>Wed, 04 Sep 2024 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[CMMB: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000000000024009837/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-24-009837</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a SEC correspondence (UPLOAD) on 2024-08-29.]]></description>
      <pubDate>Thu, 29 Aug 2024 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[CMMB: F-3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324002748/zk2431902.htm</link>
      <guid isPermaLink="false">0001178913-24-002748</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a F-3 (F-3) on 2024-08-23.]]></description>
      <pubDate>Fri, 23 Aug 2024 12:00:00 GMT</pubDate>
      <category>F-3</category>
    </item>
    <item>
      <title><![CDATA[CMMB: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324002717/zk2431846.htm</link>
      <guid isPermaLink="false">0001178913-24-002717</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a 6-K (6-K) on 2024-08-21.]]></description>
      <pubDate>Wed, 21 Aug 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[CMMB: Passive ownership stake (SC 13G)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1534248/000117891324002709/zk2431899.htm</link>
      <guid isPermaLink="false">0001178913-24-002709</guid>
      <description><![CDATA[Chemomab Therapeutics Ltd. filed a Passive ownership stake (SC 13G) on 2024-08-20.]]></description>
      <pubDate>Tue, 20 Aug 2024 12:00:00 GMT</pubDate>
      <category>SC 13G</category>
    </item>
  </channel>
</rss>